Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Penn, A. M.
Right arrow Articles by Martin, W. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Penn, A. M.
Right arrow Articles by Martin, W. R.

Neurology, Vol 45, Issue 11 2097-2099, Copyright © 1995 by American Academy of Neurology

ARTICLES

Generalized mitochondrial dysfunction in Parkinson's disease detected by magnetic resonance spectroscopy of muscle

AM Penn, T Roberts, J Hodder, PS Allen, G Zhu and WR Martin
Department of Medicine, University of Alberta, Edmonton, Canada.

OBJECTIVE: To explore mitochondrial dysfunction in Parkinson's disease (PD) using 31P magnetic resonance spectroscopy of resting muscle. DESIGN: Case-control study (28 PD patients and 28 normal controls) determining resting forearm inorganic phosphate/phosphocreatine (Pi/PCr) ratio. RESULTS: Significant difference (p = 0.004, one-tailed test) in Pi/PCr ratio between PD patients (0.122) and controls (0.104). No correlation of Pi/PCr ratio with duration, severity, or speed of onset of disease. Positive correlation of Pi/PCr ratio with age in control group; reversed in PD group. CONCLUSIONS: Suggests small generalized mitochondrial defect in PD. The possibility that earlier onset of disease is associated with more severe mitochondrial dysfunction needs further study.


This article has been cited by other articles:


Home page
 BrainHome page
M. Bogdanov, W. R. Matson, L. Wang, T. Matson, R. Saunders-Pullman, S. S. Bressman, and M. F. Beal
Metabolomic profiling to develop blood biomarkers for Parkinson's disease
Brain, February 1, 2008; 131(2): 389 - 396.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
A. H.V. Schapira
Etiology of Parkinson's disease
Neurology, May 23, 2006; 66(10_suppl_4): S10 - S23.
[Abstract] [Full Text]

Home page
 NeurologyHome page
H. Chen, S. M. Zhang, M. A. Schwarzschild, M. A. Hernan, and A. Ascherio
Physical activity and the risk of Parkinson disease
Neurology, February 22, 2005; 64(4): 664 - 669.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
I. Bourdel-Marchasson, P.-A. Joseph, P. Dehail, M. Biran, P. Faux, M. Rainfray, J.-P. Emeriau, P. Canioni, and E. Thiaudiere
Functional and metabolic early changes in calf muscle occurring during nutritional repletion in malnourished elderly patients
Am. J. Clinical Nutrition, April 1, 2001; 73(4): 832 - 838.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1995 by AAN Enterprises, Inc.